Top Markets
#1 Seeker Seeker +131.55%
#2 MowCat MowCat +108.83%
#3 Helium Helium +94.89%
#4 AI XOVIA AI XOVIA +91.25%
#5 Pons Pons +48.34%
#6 UnifAI Network UnifAI Network +33.34%
#7 Zora Zora +25.69%
#8 Bounce Bounce +25.32%
#9 Zylo Ecosystem Zylo Ecosystem +21.51%
#10 pipedog pipedog +18.86%
Coin of the day
Seeker Seeker
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
CinCor Pharma, Inc. CinCor Pharma, Inc.

CinCor Pharma, Inc.

CINC
Clasificación en acciones #11594
CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical... CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical development phase, dedicated to pioneering therapeutic solutions for cardiovascular and renal conditions. At the core of its pipeline is CIN-107, an investigational compound currently undergoing Phase II clinical trials for indications such as hypertension, primary aldosteronism, and various other cardio-renal disorders. Additionally, CIN-107 is in Phase I clinical evaluation for its potential in treating chronic kidney diseases. The company holds a significant licensing agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. Established in 2018, CinCor Pharma, Inc. maintains its principal operations in Boston, Massachusetts.
Precio por acción
$29.06
Última sincronización: 2023-02-23
Capitalización bursátil
$682.73M
Cambio (1 día)
-0.48%
Cambio (1 año)
0.00%
País
US
Comercio CinCor Pharma, Inc. (CINC)

Categoría

Healthcare
Ganancias de CinCor Pharma, Inc. (CINC)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di CinCor Pharma, Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de CinCor Pharma, Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH